RESUMO
PURPOSE: The management of complex anal fistulas remains a challenge, mainly due to the considerable risk of incontinence. We compared LIFT and VAAFT in the treatment of complex anal fistulas in terms of healing time, recurrence, continence, morbidity, and postoperative pain, focusing also on patients with local abscess at the time of surgery. METHODS: We include all patients with high trans-sphincteric anal fistula even with abscess at the time of surgery. Anorectal manometry, endoanal ultrasound, Cleveland Clinic fecal incontinence score, VAS score, and number of previous fistula treatment were recorded. The clinical examination defined healing, insufficiency or recurrence of the fistula. RESULTS: Fifty-four consecutive patients are undergoing surgery: 26 patients underwent LIFT and 28 underwent VAAFT. During the 18 months of follow-up there were no differences in terms of AM, CCFIS and VAS scores. Days of healing, failure, and recurrence rate were comparable in both groups. The subgroup of patients with local abscess undergoing LIFT showed worse results in terms of failure and recurrence rate (p < 0.05). CONCLUSIONS: Both techniques are safe and effective and can offer long-term benefits. LIFT should not be used as a first treatment in high trans-sphincteric fistula with perianal abscess.
Assuntos
Abscesso/cirurgia , Canal Anal/cirurgia , Fístula Cutânea/cirurgia , Fístula Retal/cirurgia , Abscesso/complicações , Canal Anal/fisiopatologia , Fístula Cutânea/complicações , Incontinência Fecal/etiologia , Seguimentos , Humanos , Ligadura , Manometria , Dor Pós-Operatória/etiologia , Fístula Retal/complicações , Fístula Retal/fisiopatologia , Recidiva , Estudos Retrospectivos , Falha de Tratamento , Cirurgia Vídeoassistida , CicatrizaçãoRESUMO
The authors report a case of generalized edema with low colloidal osmotic pressure of plasma in an elderly man. After the exclusion of malnutrition and any myocadic, renal or hepatic involvement it has been shown that the physiopathogenetic mechanism is based on protein-losing enteropathy. Upper and lower endoscopy of the gastrointestinal tract reveals double synchronous villous adenomas of the rectum and stomach (the latter rare but often associated with the former). It is likely that these two lesions may play an important role in the development of "anasarca" but only complete reversal of symptoms after surgical excision of tumors would demonstrate the causative relationship. The study confirms two findings already observed in the literature. The first is the increased risk of villous adenoma malignant transformation, especially where rarely located, such as in the gastric site. The other depends upon the variety of villous adenoma symptomatology. The effects of low plasmatic protein levels are prominent in this case, but clinical manifestations range form insidious signs of occult bleeding, to frank diarrhea and/or rectal bleeding, up to unusual cases of secretory diarrhea with profound dehydration and hypokalemia or malabsorption.
Assuntos
Adenoma Viloso , Neoplasias Primárias Múltiplas , Enteropatias Perdedoras de Proteínas/etiologia , Neoplasias Retais , Neoplasias Gástricas , Adenoma Viloso/complicações , Adenoma Viloso/patologia , Idoso , Idoso de 80 Anos ou mais , Biópsia , Humanos , Masculino , Neoplasias Primárias Múltiplas/patologia , Neoplasias Retais/complicações , Neoplasias Retais/patologia , Reto/patologia , Estômago/patologia , Neoplasias Gástricas/complicações , Neoplasias Gástricas/patologiaRESUMO
Ranitidine may cause liver injuries ranging from transient, subclinical serum transaminases increase every 100-1,000 treated patients to cholestatic hepatitis in less than 1/100,000. Other H2-receptor antagonists are more dangerous: 11 toxic hepatitis cases have been reported as adverse effect after 1 year of marketed ebrotidine. A 75-year-old male with ischemic cardiopathy history was started on an 8 days treatment of oral ranitidine due to pirosis, without any other changes of therapy; 48 h after drug withdrawal, light-coloured stools, dark urine and icteric scleras developed. On hospital admission, 10 days later, physical examination showed slight hepatomegaly and severe jaundice with skin excoriations followed by serum mixed bilirubin further increase and aminotransferases activities mild rise. Total bilirubin peaked at 381.33 mmol/l (5.1-17.1) and progressively returned to normal, after discharge home, in 3 months and now, 1 year later, there is no sign of liver disease. Ultrasonographic biliary anomalies and the most frequent causes of liver damage were excluded. Liver biopsy confirmed ranitidine as the most likely cause of liver toxicity since histological and ultramicroscopical study revealed a drug-induced picture. We report a rare case of intrahepatic cholestasis jaundice related to ranitidine, a widely used drug. Diagnosis would need an ethically unacceptable rechallange test.
Assuntos
Colestase Intra-Hepática/induzido quimicamente , Antagonistas dos Receptores H2 da Histamina/efeitos adversos , Icterícia Obstrutiva/induzido quimicamente , Ranitidina/efeitos adversos , Idoso , Colestase Intra-Hepática/patologia , Humanos , Icterícia Obstrutiva/patologia , MasculinoRESUMO
Multiple organ system failure (MOSF) is a severe clinical process that causes progressive renal and liver failure. Acute pancreatitis (AP) can cause MOSF. Several series document high mortality rate from necrotizing forms is associated with MOSF. The authors observed 199 cases of acute necrotizing pancreatitis in 10 years, with a mortality rate of 14.1%. MOSF occurred in 14 cases, resulting in death in 100% of affected patients. In AP, MOSF follows hemodynamic abnormalities suspected to be secondary to activation of kinins system and other vasoactive peptides that are responsible for pathogenetic mechanism of disease. Similar hemodynamic abnormalities can be observed in septic shock. Then many authors suppose causes of MOSF in AP are local (abscess, infection of pancreatic necrosis) and systemic septic complications or translocation of enteric bacteria or their endotoxins from the gut lumen. So it is important to provide prophylactic use of antibiotics that are effective against expected bacteria and also achieve a therapeutic concentration in pancreatic tissue and juice. Fluid replacement, nutritional support and other therapeutic strategies must be employed to prevent MOSF. When the MOSF is clearly developed, medical and surgical measures are unuseful and the mortality rate is very high also in an intensive care unit.
Assuntos
Insuficiência de Múltiplos Órgãos/etiologia , Pancreatite/complicações , Doença Aguda , Terapia Combinada , Humanos , Insuficiência de Múltiplos Órgãos/mortalidade , Insuficiência de Múltiplos Órgãos/fisiopatologia , Insuficiência de Múltiplos Órgãos/terapia , Pancreatite/mortalidade , Pancreatite/fisiopatologia , Pancreatite/terapia , SíndromeRESUMO
The Authors report an alternative technique for ileo-anal anastomosis in total proctocolectomy with ileal pouch. Their experience and results are discussed.
Assuntos
Canal Anal/cirurgia , Íleo/cirurgia , Proctocolectomia Restauradora/métodos , Adulto , Anastomose Cirúrgica , Colite Ulcerativa/cirurgia , Estudos de Avaliação como Assunto , Seguimentos , Humanos , Masculino , Fatores de TempoAssuntos
Neoplasias Gastrointestinais , Linfoma de Zona Marginal Tipo Células B , Adulto , Idoso , Feminino , Neoplasias Gastrointestinais/classificação , Neoplasias Gastrointestinais/diagnóstico , Neoplasias Gastrointestinais/terapia , Humanos , Enteropatias/classificação , Linfoma de Zona Marginal Tipo Células B/classificação , Linfoma de Zona Marginal Tipo Células B/diagnóstico , Linfoma de Zona Marginal Tipo Células B/terapia , Linfoma não Hodgkin/classificação , Linfoma não Hodgkin/diagnóstico , Linfoma não Hodgkin/terapia , Transtornos Linfoproliferativos/classificação , Masculino , Pessoa de Meia-IdadeRESUMO
A reduction in serum enzymes has been already observed by administering ursodeoxycholic acid to patients with chronic active hepatitis. The aim of this study was to assess whether the liver histological activity of inflammation was modified by a 12-month treatment with ursodeoxycholic acid. Thirty-six patients with chronic active hepatitis, fulfilling the inclusion criteria, were admitted to the trial. Patients were randomly allocated to receive double blind either 600 mg/day of ursodeoxycholic acid (Group A: 18 patients) or placebo (Group B: 18 patients). Clinical and biochemical follow-up was performed at acid (Group A: 18 patients) or placebo (Group B: 18 patients). Clinical and biochemical follow-up was performed at 3-month intervals. A percutaneous liver biopsy was performed before and after 1 year of treatment. Histological hepatitis activity was assessed using Knodell's numerical scoring system, while biliary damage was evaluated by an appropriate scoring system. Sixteen and 12 patients in Groups A and B, respectively, completed the clinical and biochemical follow-up. Although a reduction in serum enzymes was found in both groups, multifactorial covariance analysis showed that the reductions in alanine aminotransferase, aspartate aminotransferase and gamma glutamyl transpeptidase were significantly higher in Group A than in Group B. Biochemical remission was not observed in either group. Histological analysis showed a dichotomy between the results from the hepatitis and the biliary components of the disease process. No differences were found in the two groups before or after treatment in histological activity index, which measures the "hepatitic" component. Nor were there any significant differences in baseline values.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Hepatite Crônica/enzimologia , Hepatite Crônica/patologia , Fígado/patologia , Transferases/sangue , Ácido Ursodesoxicólico/farmacologia , Adulto , Alanina Transaminase/sangue , Aspartato Aminotransferases/sangue , Método Duplo-Cego , Feminino , Hepatite Crônica/sangue , Humanos , Fígado/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , gama-Glutamiltransferase/sangueRESUMO
We compared the effect of lactulose or lactitol on the fecal flora of 21 cirrhotic patients without hepatic encephalopathy. All were treated with an individualized disaccharide dose to achieve and maintain two semiliquid bowel movements per day. Stool pH and fecal flora were determined before and 10 days after stabilizing the cathartic effect. Increased counts of lactobacilli were obtained with both treatments. This increase, which was related to the decreased stool pH, was more constant with lactulose. In addition, lactitol decreased certain proteolytic bacteria such as enterococci and enterobacteria. Both total aerobic and anaerobic bacterial counts showed little quantitative variations with either treatment.